ABOUT US
When a five-year-old boy was blinded after a regular eye exam failed to spot a retinal detachment, his father made it his life’s work to help eye care professionals by revolutionising retinal imaging.
Optos was founded by Douglas Anderson with the goal to make a patient-friendly device to capture a digital ultra-widefield image of the retina. Today, millions of patients around the world have benefited from optomap® retinal imaging.
Acquired by Nikon Corporation in 2015, Optos now operates within the Nikon Healthcare division. The company recently celebrated its 30th anniversary and is recognised as a leading provider of advanced imaging devices that support a more complete approach to patient care. Optos generates approximately $300 million in revenue, employs around 650 people worldwide, and manufactures 60% of its products in the UK.
The Clinical & Regulatory Project Coordinator (CRPC) is responsible for the day-to-day coordination of clinical and regulatory projects, ensuring project plans remain accurate, current, and aligned with key milestones and deliverables. The CRPC monitors project progress, identifies potential risks and issues, and facilitates timely resolution of action items.
Working closely with cross-functional teams and stakeholders, the CRPC serves as a central point of coordination, supporting effective communication, maintaining project documentation, and preparing project status reports. The primary purpose of the role is to coordinate project activities, timelines, meetings, and deliverables to support the successful execution of clinical and regulatory objectives.
ESSENTIAL DUTIES AND RESPONSIBILITIES
MINIMUM QUALIFICATIONS
BENEFITS
At Optos, we offer a highly competitive compensation and benefits package.
EQUAL OPPORTUNITIES EMPLOYER
We are an equal opportunities employer and welcome applications from all suitably qualified persons regardless of their race, sex, disability, religion/belief, sexual orientation, age or protected veteran status.
If you feel you have the necessary skills and experience and want to join a great team, please click on the Apply button!

When a five-year-old boy was blinded after a regular eye exam failed to spot a retinal detachment, his father made it his life’s work to help eye care professionals by revolutionising retinal imaging. Optos was founded by Douglas Anderson with the goal to make a patient-friendly device to capture a digital ultra-widefield image of the retina. Today, millions of patients around the world have benefited from optomap® retinal imaging. You will find optomap systems in many independent High Street optometrists, as well as eye clinics at Great Ormond Street Hospital in London and Harvard Medical Center in Massachusetts.
Our core products produce high resolution optomap images of 82% or 200◦ of the retina, something no other imaging device is capable of in a single comfortable capture. The most recent innovation from Optos integrates ultra-widefield retinal imaging and image-guided Optical Coherence Tomography (OCT). This combined device facilitates the early detection, management and effective treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. More than 1,000 published and ongoing clinical trials as well as thousands of case studies and testimonials show the long-term value of optomap imaging and OCT in diagnosis, treatment planning, and patient engagement.
As a division of Nikon Co. Ltd, Japan since 2015, Optos is approaching its 30th anniversary and proud to be recognized as a leading provider of devices to eye care professionals to provide a more complete approach to patient care.